NCT00403520View on ClinicalTrials.gov

Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers

PHASE4CompletedINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

August 31, 2010

Conditions

Alzheimer's Disease

Interventions

DRUG

Experimental 1

Drug: Donepezil Hydrochloride 10 mg orally for 12 months

DRUG

Placebo Comparator

Drug: Placebo Matching placebo orally for 12 months

Trial Locations (1)

Unknown

CHU Gui de Chauliac, Montpellier

All Listed Sponsors

lead

Eisai Inc.

INDUSTRY

NCT00403520 - Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers | Biotech Hunter | Biotech Hunter